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ABSTRACT Escherichia coli, an intestinal Gram-negative bacterium, has been shown to
be associated with a variety of diseases in addition to intestinal infections, such as
urinary tract infections (UTIs), meningitis in neonates, septicemia, skin and soft tissue
infections (SSTIs), and colisepticemia. Thus, for nonintestinal infections, it is catego-
rized as extraintestinal pathogenic E. coli (ExPEC). It is also an opportunistic patho-
gen, causing cross infections, notably as an agent of zoonotic diseases. However,
comparative genomic data providing functional and genetic coordinates for ExPEC
strains associated with these different types of infections have not proven conclu-
sive. In the study reported here, ExPEC E. coli isolated from SSTIs was characterized,
including virulence and drug resistance profiles, and compared with isolates from
patients suffering either pyelonephritis or septicemia. Results revealed that the ma-
jority of the isolates belonged to two pathogenic phylogroups, B2 and D. Approxi-
mately 67% of the isolates were multidrug resistant (MDR), with 85% producing
extended-spectrum beta-lactamase (ESBL) and 6% producing metallo-beta-lactamase
(MBL). The blaCTX-M-15 genotype was observed in at least 70% of the E. coli isolates
in each category, conferring resistance to an extended range of beta-lactam antibi-
otics. Whole-genome sequencing and comparative genomics of the ExPEC isolates
revealed that two of the four isolates from SSTIs, NA633 and NA643, belong to pan-
demic sequence type ST131, whereas functional characteristics of three of the ExPEC
pathotypes revealed that they had equal capabilities to form biofilm and were resis-
tant to human serum. Overall, the isolates from a variety of ExPEC infections demon-
strated similar resistomes and virulomes and did not display any disease-specific
functional or genetic coordinates.
IMPORTANCE Infections caused by extraintestinal pathogenic E. coli (ExPEC) are of
global concern as they result in significant costs to health care facilities manage-
ment. The recent emergence of a multidrug-resistant pandemic clone, Escherichia
coli ST131, is of primary concern as a global threat. In developing countries, such as
India, skin and soft tissue infections (SSTIs) associated with E. coli are marginally ad-
dressed. In this study, we employed both genomic analysis and phenotypic assays to
determine relationships, if any, among the ExPEC pathotypes. Similarity between an-
tibiotic resistance and virulence profiles was observed, ST131 isolates from SSTIs
were reported, and genomic similarities among strains isolated from different dis-
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ease conditions were detected. This study provides functional molecular infection
epidemiology insight into SSTI-associated E. coli compared with ExPEC pathotypes.
KEYWORDS Escherichia coli, genomics, sepsis
Escherichia coli is one of the most important agents of extraintestinal infections, withthe potential to cause infection in almost any anatomical site. It can be grouped into
pathotypes, such as uropathogenic E. coli (UPEC), septicemia-associated E. coli (SePEC),
skin and soft tissue infection (SSTI)-associated E. coli, neonatal-meningitis-causing E. coli
(NMEC), and avian-pathogenic E. coli (APEC) (1, 2). Urinary tract infections (UTIs) alone
account for about 25% of all cases of septic shock, while soft tissue infections represent
10% of reported severe sepsis cases (3, 4). Clinical stages of UTIs vary from nonsymp-
tomatic acute infection to severe septic shock. In the latter case, the infection generally
progresses from the urinary tract to the bladder (cystitis) and from the bladder to the
kidneys (pyelonephritis) and finally into the bloodstream (urosepsis). Skin and soft
tissue infections (SSTIs) are major bacterial infections, often self-limiting but in severe
cases requiring hospitalization and parenteral antibiotic therapy. With the indiscrimi-
nate use of antibiotics and emergence of multidrug-resistant (MDR) organisms, such as
sequence type 131 (ST131) and carbapenem-resistant strains, treatment has become
quite challenging (5–7). Despite the fact that SSTI E. coli is an important pathotype, to
our knowledge only UTI E. coli isolates isolated in India have been characterized (8, 9).
This study provides a functional molecular infection insight for E. coli associated with
SSTI. Phylogenetic relationships, virulence profiles, antibiotic resistance patterns, and
functional attributes were determined, and whole genomes were sequenced and
compared with septicemia and pyelonephritis isolates from the same setting of ende-
micity in India.
RESULTS
Phylogenetic groups and antimicrobial resistance. The majority of the isolates
included in this study were assigned to virulence B2 (36%) and D (29%) phylogroups,
with 23% in the A group and 12% in the B1 group (Table 1). Of the three disease types,
more than half of the isolates fell into B2 and D phylogroups. In total, 73 isolates (93%)
were resistant to at least one of six antimicrobial agents, with highest resistance being
shown to ciprofloxacin (86%), followed by tetracycline (77%), co-trimoxazole (72%),
gentamicin (31%), chloramphenicol (23%), and fosfomycin (5%). Details of all bacterial
isolates, including their antimicrobial resistance patterns, are provided in Table S1 in
the supplemental material. Overall, 67% of the total E. coli isolates were found to be
multidrug resistant (MDR), in which pyelonephritis, septicemia, and SSTI contributed
fractions of 0.40, 0.32, and 0.26, respectively (Table 2). The extended-spectrum-beta-
lactamase (ESBL)-producing E. coli strains were found to comprise as much as 85% of
the isolates and were similar in all three disease types. Only 6% of the isolates were
metallo-beta-lactamase (MBL) producers. Resistance gene profiling was compatible
with the phenotypic observations, with blaCTX-M-15 being the predominant genotype
and NDM-1 being a common occurrence among all MBL producers (Tables 1 and 2). The
gene sul1 was detected in approximately 71% of the isolates in all three categories,
conferring resistance to sulfonamides, while the plasmid-based fluoroquinolone resis-
tance gene [aac(6=)-lb-cr] was detected in 30% and 71% of the pyelonephritis and SSTI
isolates, respectively.
Virulence genotypes. Analysis of the virulence genotype fimH showed that it was
present in 90% of the isolates in each category, with the exception of SSTI isolates
(62%). Interestingly, papC was found to be prevalent in septicemia and pyelonephritis
isolates. However, afaB/C and sfaD/E were present in various proportions in the three
groups. Of the three toxin types, cvaC was detected, to a lesser extent, in pyelonephritis
and septicemia isolates. The prevalence of protectin genes traT and ibeA was the same
as that of iron acquisition genes iroN and iucD in all three groups (Table 1).
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Whole-genome analysis of resistome and virulome. Twelve strains, comprising
four from each of the three disease types, were subjected to comparative genomic
analysis to obtain a broader perspective of the complexity of the E. coli disease types.
Genome sequence data for four strains were also included from previous and ongoing
studies, including reference strains Escherichia coli NA097 and NA114 (10, 11), and eight
isolates of this study were subjected to whole-genome sequencing (WGS). Whole-
genome-based resistome profiles confirmed the strains to be multidrug resistant. All
strains demonstrated relatively similar combinations of resistance genes encoding










Skin and soft tissue
infections (n  21)b
Phylogenetic grouping, (no. [%] of strains)
A (18 [23]) 2 (7) 8 (30) 8 (38)
B1 (9 [12]) 3 (10) 4 (15) 2 (10)
B2 (28 [36]) 15 (50) 7 (26) 6 (29)
D (23 [29]) 10 (33) 8 (30) 5 (24)
Virulence factors
Toxins sat 16 (53) 9 (33) 6 (29)
usp 10 (33) 6 (22) 6 (29)
cvaC 6 (20) 6 (22) 15 (71)*
Adhesins fimH 27 (90) 24 (89) 13 (62)*
papC 28 (93) 25 (93) 5 (24)*
afaB/C 8 (27) 1 (4) 1 (05)
sfaD/E 2 (7) 2 (7) 1 (05)
Protectins traT 5 (17) 4 (15) 6 (29)
ibeA 3 (10) 3 (11) 1 (5)
Iron acquisition iroN 27 (90) 21 (78) 16 (76)
iucD 19 (63) 16 (59) 15 (71)
Antibiotic resistance profiling: antibiotic class
ESBL blaCTX-M-15 21 (70) 24 (89) 17 (81)
blaTEM 15 (50) 14 (52) 4 (19)*
blaCTX-M-15  blaTEM 11 (37) 12 (44) 4 (19)
Metallo-beta-lactamase blaNDM1 0 (0) 1 (4) 5 (24)*
Tetracyclines tetA 20 (67) 17 (63) 8 (38)
Aminoglycosides strA 14 (47) 10 (37) 9 (43)
Fluoroquinolone aac(6=)-lb-cr 9 (30) 13 (48) 15 (71)
Sulfonamides sul1 25 (83) 23 (82) 15 (71)
sul2 12 (40) 7 (26) 6 (29)
Trimethoprim dhfr 8 (27) 9 (33) 2 (10)
Integrin int1 18 (60) 15 (56) 13 (62)
aTotal number of strains was 78.
bAsterisks denote a P value of 0.05 compared to the septicemia group of strains.
TABLE 2 Pathotypes and phenotypic drug resistance and multidrug resistance phenotypes
Antimicrobial class
or phenotype Specific drug
% overall prevalence of
resistance phenotype in
Indian population





Skin and soft tissue
infections (n  21)
Quinolone/fluoroquinolone Ciprofloxacin 86 0.37 0.34 0.28
Sulfonamide/trimethoprim Co-trimoxazole 72 0.43 0.36 0.21
Aminoglycosides Gentamicin 31 0.33 0.41 0.25
Phenicols/phosphonic acid derivatives Chloramphenicol 23 0.39 0.50 0.11
Fosfomycin 5 0.00 0.25 0.75
Tetracyclines Tetracycline 77 0.43 0.35 0.22
ESBL phenotype Cefotaxime 85 0.36 0.36 0.27
MBL phenotype Meropenem 06 0.00 0.16 0.83
Multidrug resistance 67 0.40 0.32 0.26
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antibiotic efflux pumps, regulators, antibiotic inactivation, and target modification
(Fig. 1b). The virulomes also showed very little pathotype specificity (Fig. 1a). Based on
in silico multilocus sequence typing (MLST) results, two SSTI strains (NA633 and NA643)
were assigned to the pandemic ST131 clone, while the rest of the strains were assigned
to different sequence types (STs), namely, ST38, ST68, ST405, and ST 617 (Table 3).
Results of comparative genomic analyses using the BLAST Ring Image Generator
(BRIG) platform showed sequence-type-specific similarities, i.e., all five ST131 strains
FIG 1 Heat map of virulome (a) and resistome (b) data generated from whole-genome comparative genomics for 12 strains that included four strains from
each of the infection categories septicemia, pyelonephritis, and SSTI. Black boxes represent presence, and gray boxes represent absence.
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had similar arrangements of genomic regions, whereas isolates belonging to other
STs had dissimilar regions (Fig. 2a). Clearly, disease-specific genomic features were
not detected.
Functional virulence determination. A total of 30 E. coli isolates, comprising 10
from each category, were analyzed for functional virulence determinants. Results
revealed biofilm formation capabilities for all isolates when tested using M63
medium and incubation for 48 h at 28°C. Most were strong biofilm formers (Fig. 2c)
and also able to grow in human serum (50%). Resistance to serum, i.e., demon-
strating no deleterious effect, was variable among the isolates, but the difference
was insignificant (Fig. 2b).
DISCUSSION
Infections caused by extraintestinal pathogenic E. coli (ExPEC) are common world-
wide. In the present study, we observed that E. coli strains isolated from SSTI, septice-
mia, and pyelonephritis were predominately B2 and D phylogroups (Table 1), which are
considered virulent E. coli (12, 13). The observations of this study are similar to those of
Petkovsek et al. (14), who reported that SSTI E. coli possessed virulence factors (VFs).
Ananias and Yano (15) also showed VFs to be common among different sepsis-
associated E. coli (SePEC) strains notably able to invade Vero cell lines.
Recent studies reported a global increase in multidrug resistance (MDR) and
extended-spectrum beta-lactamase (ESBL) genotypes among ExPEC strains associated
with infections (16, 17). In the present study, the majority (67%) of ExPEC isolates were
MDR, with CTX-M-15 being the predominant ESBL genotype (Tables 1 and 2). Further-
more, the combination of ESBL and fluoroquinolone resistance was the most frequent,
followed by that of CTX-M-15 positivity (CTX-M-15), fluoroquinolone resistance, and
co-trimoxazole resistance and that of CTX-M-15, fluoroquinolone resistance, co-
trimoxazole resistance, and tetracycline resistance (Table 4). The resistome (Fig. 1b),
based on WGS, showed the presence of multiple genes, whereas the MBL phenotype
in all isolates was associated with the presence of the NDM gene, reflecting dissemi-
nation of NDM carbapenem resistance in India (7).
ExPEC is known to be evolving and disseminating globally via clonal expansion, with
clones of similar genetic architectures but also demonstrating strain-specific features
(11, 18). Here, we observed similarities in virulence and resistance coordinates of strains
belonging to sequence types (STs) ST131, ST38, ST68, ST405, and ST617. Interestingly,
ST-specific commonality but not disease-specific similarity was observed (Fig. 2a). These
results support the conclusion that strains of diverse STs are capable of causing similar
infections. We also report for the first time the occurrence in India of E. coli isolates from
SSTIs that carry ST131.
In summary, the results of this study indicate that ExPEC isolates associated with
pyelonephritis, septicemia, and SSTIs comprise overlapping phylogroups and patterns
of virulence, drug resistance, genomic, and functional properties but are not specifically
associated with pathotypes.

















content (%) N50 value
NA643 MJDL00000000 2,136,944 108.5 112 ST131 5,322,063 5,257 87.4 17 50.72 216,749
NA635 MJDK00000000 1,822,696 91.8 122 ST617 4,948,859 4,769 87.2 12 50.78 164,858
NA633 MJDJ00000000 1,878,242 94.6 81 ST131 5,275,425 5,212 87.7 17 50.68 265,266
NA447 JWHS00000000 1,500,566 45 239 ST617 5,091,202 4,990 85.7 15 50.68 52,237
NA267 MJDI00000000 2,092,350 105 164 ST405 5,393,308 5,229 86.8 13 50.51 118,812
NA259 MJGD00000000 1,758,550 88.6 162 ST405 5,400,321 5,260 86.9 13 50.51 118,812
NA056 MKHD00000000 1,513,364 78 98 ST68 5,322,471 5,099 87.6 12 50.54 143,398
NA057 JSXL00000000 1,913,156 57 150 ST38 5,286,256 5,173 86.5 8 50.5 120,832
aCDS, coding sequences.
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MATERIALS AND METHODS
Bacterial strains. A total of 78 isolates, including 21 from patients suffering infections associated
with skin and soft tissues, were obtained from the D. Y. Patil Hospital, Pune, India, during 2015. Also, 57
E. coli strains isolated during January 2009 to December 2012 were included in the study. All isolates
were identified and preserved employing standard laboratory methods of the hospital as previously
published (8) and the protocols were approved by Institutional Biosafety Committee (IBSC) of
University of Hyderabad, Hyderabad, India.
Preparation of DNA template and E. coli phylogenetic grouping. Template DNA was prepared
using the boiling lysis method. In brief, 100 l of the bacterial cultures was boiled at 95°C for 20 min and
centrifuged at 6,000 rpm for 10 min. The supernatant obtained was used as the template. All E. coli
isolates were classified into four major phylogenetic groups by multiplex PCR using three molecular
markers: chuA, yjaA, and tspE4 (19). After electrophoresis (1.5% agarose), gel images were captured and
isolates were assigned to phylogenetic groups based on the dichotomous decision tree of the work of
Clermont et al. (19).
FIG 2 (a) BLAST Ring Image Generator (BRIG) images of 12 strains, including four from each infection category, where each concentric ring represents genomes
sequentially in groups, e.g., septicemia, pyelonephritis, and SSTI, generated with the NA097 septicemia strain serving as a reference. (b) Serum resistance tested
using 50% human serum. (c) Biofilm formation assay for 10 strains from each category, repeated twice in technical triplicate. ns, nonsignificant; SBF, specific
biofilm formation; ve, positive.
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ESBL screening and antimicrobial resistance. ESBL production was confirmed phenotypically,
using guideline M31-A3 of the Clinical and Laboratory Standards Institute (CLSI) (20). Resistance to
carbapenems was determined by using Etest (HiMedia), and susceptibility was defined by breakpoints
per CLSI (20). All E. coli isolates were tested for resistance to six major classes of non--lactam antibiotics,
employing standard disc agar diffusion on Muller-Hinton agar (HiMedia) (20). Six antimicrobial discs
(HiMedia) were used: ciprofloxacin (30 g), chloramphenicol (30 g), fosfomycin (200 g), gentamicin
(10 g), sulfamethoxazole-trimethoprim (25 g), and tetracycline (30 g). Isolates showing resistance to
three or more antimicrobial drugs are considered multidrug resistant (MDR).
Antimicrobial resistance genotyping. PCR was used to detect -lactamase genes (blaTEM, blaSHV,
and blaCTX-M-15) in ESBL-positive E. coli isolates (21, 22). The presence of genes encoding carbapenemase
was detected using selected primers (23). Resistance genes {tetracycline resistance [tetA], sulfonamide
resistance [sul1 and sul2], aminoglycoside resistance [strA], the aminoglycoside acetyltransferase [aac(6=)-
lb-cr], and trimethoprim resistance [dhfr]} were determined by PCR using primers and programs reported
elsewhere (24, 25). The gene int1, encoding class 1 integrase, was also detected by PCR (26).
Virulence genotyping. The ExPEC isolates were tested for the presence of 11 E. coli virulence genes
(VGs) associated with sepsis-related pathophysiology. The genes targeted were of the following four
categories: (i) bacterial adhesins (papC, fimH, afaB/C, and sfaD/E) (27–30), (ii) toxins (usp, sat, and cvaC)
(31–33), (iii) protectants (traT and ibeA) (33, 34), and (iv) the iron acquisition system (iroN and iucD)
(30, 35).
Whole-genome sequencing and comparative genomics. Eight of the isolates were sequenced, and
comparative genomics analyses were done, including four strains from previous and ongoing studies,
providing virulome, resistome, and whole-genome comparisons. Briefly, paired-end sequence data for
eight strains were obtained using Illumina MiSeq for the following in silico analysis. The NGS QC Toolkit
(v2.3.3) (36) was used to filter high-quality reads, followed by contig assembly using SPAdes Genome
Assembler (v3.6.1) (37). Numbers of raw reads, respective read lengths, genome coverage obtained after
filtering, and total number of contigs were computed. The generated de novo contigs were ordered and
scaffolded using Contig-Layout-Authenticator (CLA) (38). Final draft genomes were obtained by merging
scaffolds using a series of N’s. Draft genomes were submitted to the RAST (39) server for annotation, and
genome statistics from the resulting file were extracted using Artemis (40). The sequence type (ST) of
each strain was determined by submitting contigs to https://cge.cbs.dtu.dk/services/MLST/.
Twelve strains, including eight from the current study and four from earlier reported and ongoing
studies, belonging to different pathotypes were used for the following comparative analysis. BRIG (41)
was used to visualize genome variation of the 12 strains. GeneMarkS (42) was used to predict protein
sequences. BLASTp (43) analysis of the putative protein sequences was performed against the database
of E. coli virulence genes downloaded from the Virulence Factors Database (VFDB) (44), providing a
virulence profile for each strain. A specific virulence gene was considered present only if the BLASTp hit
had identity greater than 60% and query coverage greater than 85%. The presence-absence status of all
virulence genes carried by each strain was represented in the form of a heat map using R. A similar heat
map was generated for putative resistance-related genes from the Comprehensive Antibiotic Resistance
Database (CARD) (45), using BLASTp.
Phenotypic virulence determination. Biofilm formation was determined using M63 minimal me-
dium as described earlier (13, 46). Briefly, bacteria grown overnight were diluted to an optical density at
600 nm (OD600) of 0.05 in M63 medium, and 200 l of each was inoculated in triplicate in a 96-well
microtiter plate. OD600 was measured, and the plate was covered with permeable sealing and incubated
at 28°C for 48 h without shaking. Growth was measured after 48 h as OD600 using a microtiter plate
reader. Medium was removed gently, washed three times with deionized water, and dried. Bacteria were
fixed with methanol (99%) for 15 min and stained with 1% crystal violet (30 min) after air drying. Plates
were washed three times with deionized water and air dried again. The fixed stained bacteria were
resolubilized using 200 l of ethanol-acetone (80:20), and absorbance was measured at 570 nm. Specific
biofilm formation (SBF) was obtained using the formula SBF  (AB  CW)/G, where AB is absorbance at
570 nm, CW is OD570 of control well (without bacteria), and G is growth measured by the formula G 
OD600(48 h)  OD600(0 h).
Serum bactericidal activity was assayed using 50% human serum as reported previously (13, 46).
Briefly, 5 l of overnight-grown culture was inoculated in 495 l of fresh LB broth and allowed to grow
for 1.5 h at 37°C at 200 rpm. The bacterial cells were pelleted and resuspended in 1 ml of sterile 1
phosphate-buffered saline (PBS). Thirty microliters of bacteria was added to 270 l of 50% human serum
in a 96-well microtiter plate in triplicates, and 30 l of sample was taken out and plated on LB agar plates
after dilution. The plate was covered and allowed to grow for 3 h at 37°C at 100 rpm. After 3 h of
incubation, 30 l of sample was collected again from each well, diluted, and plated on LB agar plates.
The bacteria were enumerated after overnight incubation at 37°C, and growth in serum was calculated
by subtracting the CFU of 0 h from that of 3 h. A graph was plotted, and results were analyzed. Both of
the assays were performed twice and in triplicate on a subset of 10 isolates from each category.
Statistical analysis. Statistical analysis of data for virulence and resistance genes was performed
employing chi-square and Mann-Whitney tests for serum resistance and biofilm formation, respectively.
Accession number(s). GenBank accession numbers of the eight genomes sequenced for this study
are MJDL00000000 (NA643), MJDK00000000 (NA635), MJDJ00000000 (NA633), JWHS00000000 (NA447),
MJDI00000000 (NA267), MJGD00000000 (NA259), MKHD00000000 (NA056), and JSXL00000000 (NA057).
GenBank accession numbers of the other four genomes used are MIPU00000000 (NA114), JSXJ00000000
(NA097), JSXN00000000 (NA101), and MVIO00000000 (NA090).
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